SCHEMBL129048

SCHEMBL129048

O=C(C=Cc1cccc(O)c1)c1ccccc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 7/20 1.00
MAOA P21397 3/20 1.00
HSP90AA1 P07900 1/20 1.00
MAPT P10636 4/20 0.73
BCHE P06276 1/20 0.73
CYP2C19 P33261 1/20 0.73
KDM4E B2RXH2 3/20 0.69
MAPK1 P28482 3/20 0.69
KMT2A Q03164 3/20 0.69
PTGS1 P23219 2/20 0.69
PTGS2 P35354 2/20 0.69
GAA P10253 1/20 0.69
NPSR1 Q6W5P4 1/20 0.69
MYOC Q99972 1/20 0.69
MEN1 O00255 2/20 0.69
ALDH1A1 P00352 2/20 0.69
CYP3A4 P08684 2/20 0.69
HPGD P15428 2/20 0.69
ALOX15 P16050 2/20 0.69
SMN1; SMN2 Q16637 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25188844 1.00 MAOB (1.00) MAOBMAOAHSP90AA1MAPTBCHE
SCHEMBL30383075 1.00 MAOB (1.00) MAOBMAOAHSP90AA1MAPTBCHE
SCHEMBL30383896 1.00 MAOB (1.00) MAOBMAOAHSP90AA1MAPTBCHE
SCHEMBL5084278 1.00 MAOB (1.00) MAOBMAOAHSP90AA1MAPTBCHE
SCHEMBL25207247 0.92 MAOB (0.84) MAOBMAOAHSP90AA1MAPTBCHE
SCHEMBL25219805 0.87 MAOB (0.77) MAOBMAOAHSP90AA1MAPTBCHE
SCHEMBL25194592 0.87 MEN1 (0.79) MAOBMAOAHSP90AA1MAPTCYP2C19
SCHEMBL14027262 0.87 MEN1 (0.79) MAOBMAOAHSP90AA1MAPTCYP2C19
SCHEMBL30383752 0.87 MEN1 (0.79) MAOBMAOAHSP90AA1MAPTCYP2C19
SCHEMBL25208163 0.86 MAOA (0.75) MAOBMAOAHSP90AA1MAPTBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 309 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260033492-A1 Pest Repellents and Uses Thereof SENSORYGEN INC (US) 2026-02-05 US disclosed
US-20260014100-A1 Compositions and Methods for Treating Bleeding and Bleeding Disorders YEWSAVIN INC (US) 2026-01-15 US disclosed
US-12343317-B2 Compositions and methods for treating bleeding and bleeding disorders YewSavin, Inc. (US) 2025-07-01 US disclosed
US-12280129-B2 Compositions and methods for improved skin care PINSKY MARK A (US) 2025-04-22 US disclosed
WO-2024233598-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS YewSavin, Inc. (US) 2024-11-14 WO disclosed
US-20230292754-A1 Pest Repellents and Uses Thereof UNIVERSITY OF CALIFORNIA RIVERSIDE 2023-09-21 US disclosed
US-20230190679-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS YewSavin, Inc. (US) 2023-06-22 US disclosed
WO-2023086388-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS YewSavin, Inc. (US) 2023-05-19 WO disclosed
US-20220117863-A1 COMPOSITIONS AND METHODS FOR IMPROVED SKIN CARE PINSKY MARK A (US) 2022-04-21 US disclosed
US-20210338558-A1 USE OF COLLAGEN BINDING DOMAINS TO DELIVER PRODUCTS TO SKIN FABIUS BIOTECHNOLOGY (US) 2021-11-04 US disclosed
WO-2000062745-A2 SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES THE PROCTER & GAMBLE COMPANY (US) 2000-10-26 WO disclosed
WO-2000062743-A2 SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES THE PROCTER & GAMBLE COMPANY (US) 2000-10-26 WO disclosed
WO-2000062744-A2 SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES THE PROCTER & GAMBLE COMPANY (US) 2000-10-26 WO disclosed
WO-2000062740-A2 SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES THE PROCTER & GAMBLE COMPANY (US) 2000-10-26 WO disclosed
WO-2000042961-A2 WATER-FLUX LIMITING CLEANSING ARTICLES THE PROCTER & GAMBLE COMPANY (US) 2000-07-27 WO disclosed
US-6093411-A AN EMULSION COMPRISING FLAVONOIDS FOR PREVENTING OR TREATING SKIN DISORDERS THE PROCTER & GAMBLE COMPANY (US) 2000-07-25 US disclosed
US-6051602-A METHODS FOR PREVENTION OR TREATING SKIN DISORDERS USING FLAVONOID COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2000-04-18 US disclosed
WO-1999047118-A1 COMPOSITIONS FOR REGULATING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 1999-09-23 WO disclosed
WO-1999047113-A1 COMPOSITIONS FOR REGULATING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 1999-09-23 WO disclosed
WO-1999047119-A1 METHODS FOR REGULATING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 1999-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210338558-A1 USE OF COLLAGEN BINDING DOMAINS TO DELIVER PRODUCTS TO SKIN COL14A1, COL2A1, COL1A1 MAOB 3131/4885MAOA 3005/4885HSP90AA1 245/4885
US-20260014100-A1 Compositions and Methods for Treating Bleeding and Bleeding Disorders SERPINC1, F2, F13B MAOB 1004/4885MAOA 1902/4885HSP90AA1 437/4885
US-20230190679-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS SERPINC1, SERPINE1, SERPINH1 MAOB 2435/4885MAOA 3145/4885HSP90AA1 281/4885
US-20260033492-A1 Pest Repellents and Uses Thereof F3, TFPI, FLI1 MAOB 1790/4885MAOA 602/4885HSP90AA1 726/4885
US-12343317-B2 Compositions and methods for treating bleeding and bleeding disorders SERPINC1, SERPINE1, SERPINH1 MAOB 2435/4885MAOA 3145/4885HSP90AA1 281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.